Symbol

RARE Stock Financials and Fundamentals

Company Info

Company Full Name

Ultragenyx Pharmaceutical Inc.

Full name of the company.

Industry Name

MEDICAL-BIOMED/GENETICS

Industry name

Major Industry Name

DRUGS

Major industry name

Sector Name

Medical

Sector name

Market Info

Current Price

$22.52

Current price of the stock

Trading Volume

$1M

Trading volume of the stock

Market Capitalization

$2.3B

Market capitalization of the company

Market Cap Category

Mid Cap

Category of market capitalization

Long-Term Growth Estimate

43.08%

Long-term growth mean estimate

Analyst Rating Mean

4.77

Mean analyst rating

Potential Upside

169.81%

Potential price appreciation based on analyst price targets

EPS Surprise Percentage Difference

-7.50%

Percentage difference of EPS surprise

Dividends

Dividend Change (1 Year)

Dividend change over 1 year

Dividend Rate

$0.00

Shows the amount of dividend paid

Balance Sheet

Total Debt to Equity Ratio

Total debt to total equity ratio

Current Ratio

1.89

Current ratio

Company Profitability

Gross Profit Margin

82.50%

Gross profit margin

Operating Profit Margin

-106.85%

Operating profit margin

EBIT Margin

-106.85%

Earnings before interest and taxes (EBIT) margin

EBITDA Margin

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin

Pretax Profit Margin

-112.26%

Pretax profit margin

Net Profit Margin

-112.81%

Net profit margin

Return on Equity (ROE)

-1969.82%

Measures profitability relative to shareholders' equity

Return on Tangible Equity

86.66%

ROE excluding intangible assets

Return on Assets (ROA)

-15.16%

Measures profitability relative to total assets

Return on Invested Capital (ROIC)

-1969.79%

Measures profitability relative to invested capital

Management Effectiveness

Asset Turnover (quarterly)

0.13

Asset turnover ratio

Inventory Turnover (quarterly)

0.54

Inventory turnover ratio

Receivables Turnover (quarterly)

1.42

Receivables turnover ratio

Days Sales Outstanding

63.33

Average number of days it takes to collect receivables

Valuation Measures

Price-to-Earnings (P/E) Ratio

-3.86

Measures valuation relative to earnings

Forward P/E Ratio

-5.33

P/E based on future earnings estimates

Price-to-Sales (P/S) Ratio

3.59

Measures valuation relative to sales

Price-to-Book (P/B) Ratio

239.16

Measures valuation relative to book value

Price-to-Operating Cash Flow (P/OCF) Ratio

-1.78

Measures valuation relative to operating cash flow

Price-to-Free Cash Flow (P/FCF) Ratio

-1.75

Measures valuation relative to free cash flow

Cash Flow Statement

Net Acquisitions/Divestitures

Indicates company's M&A activity